WW ANNOUNCES STUDY RESULTS SHOWING CLINICALLY SIGNIFICANT IMPROVEMENTS FOR PEOPLE LIVING WITH DIABETES ON CUSTOMIZED PROGRAM June 4, 2022 11:01 am|Positive Clinical Trial Results Revealed at ADA 82nd Scientific Sessions
Risk of Severe Diabetes Ketoacidosis Spiked Among Pediatric Type 1 Diabetes Patients During the Pandemic June 4, 2022 11:00 am|Meta-Analysis Compared Rate of Life-Threatening Diabetes Complication Among Children Prior to and During the COVID-19 Pandemic
Lilly's AWARD-PEDS trial investigating use of Trulicity® (dulaglutide) in youth and adolescents with type 2 diabetes showed superiority in A1C reduction vs placebo June 4, 2022 11:00 am|AWARD-PEDS results presented at ADA’s 82nd Scientific Sessions® and simultaneously published in the New England Journal of Medicine…
Once Weekly Drug Helps Control Pediatric Type 2 Diabetes June 4, 2022 11:00 am|Data Shows Potential Breakthrough Treatment Option for Glucose Management in Adolescents with Uncontrolled Diabetes
Individuals with Diabetes are Up to Four Times More Likely to Develop Long COVID-19 June 4, 2022 11:00 am|Diabetes Study Adds to Growing Body of Data Around Risk Factors for Long-Standing Effects of COVID-19 Infection
Swiatek beats Gauff 6-1, 6-3 for 2nd French Open title June 4, 2022 10:40 am|PARIS (AP) — Top-ranked Iga Swiatek beat 18-year-old American Coco Gauff 6-1, 6-3 in the French Open women’s…
‘Doc’ Antle of ‘Tiger King’ fame arrested by FBI June 4, 2022 10:33 am|MYRTLE BEACH, S.C. (WMBF/Gray News) – The owner of the Myrtle Beach Safari, who is best known nationally…
9 shot after argument leads to shooting at north Phoenix strip mall, police say June 4, 2022 10:22 am|PHOENIX (Arizona’s Family/Gray News) – Phoenix police say nine people, including an older teenage boy, was shot at…
SURMOUNT-1 Study Finds Individuals with Obesity Lost up to 22.5% of their Body Weight when Taking Tirzepatide June 4, 2022 10:02 am|American Diabetes Association Symposium to Highlight Once Weekly Drug as Potential Treatment for Obesity
Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight June 4, 2022 10:02 am|Detailed results from Lilly’s first phase 3 trial in obesity or overweight presented at the American Diabetes Association’s® 82nd…